Top Story

FDA: Use of TAVR system expanded to include aortic valve-in-valve replacement

March 30, 2015

The FDA has expanded the approved use of the CoreValve system to include aortic valve-in-valve replacement, according to an agency press release.

The new approval expands the authorized use of the transcatheter aortic valve replacement system (Medtronic) to patients in need of tissue aortic valve replacement who are also at high or extreme risk for complications associated with traditional open-heart surgery, according to the release.

4143177886001 th Meeting News CoverageVideo

VIDEO: Results from three trials suggest 'significant progress' for TAVR technology

March 30, 2015
SAN DIEGO — In this video, Steven R. Bailey, MD, chief of cardiology at the University of Texas Health Sciences Center and Cardiology Today's Intervention
Krishna J. Rocha-Singh, MD, FACC, FAHA In the Journals

DURABILITY II: Single self-expanding stent linked to sustained outcomes at 3 years

March 30, 2015
Use of a single self-expanding stent up to 20 cm in length in long femoropopliteal lesions was associated with acceptable stent patency and freedom from clinically…
In the Journals

OSA may predict serious adverse outcomes following stroke, IHD

March 30, 2015
Obstructive sleep apnea appears to be linked with an increased risk for stroke, ischemic heart disease, and all-cause mortality among patients following vascular events…
FDA News

New administration option for ticagrelor now approved

March 30, 2015
For patients with ACS who are unable to swallow whole tablets, ticagrelor is now approved by the FDA to be crushed and administered in water by swallowing or via…
More News Headlines »
CME
Obesity Consults: Volume 2, Number 4 Obesity and the Cardiovascular System

Obesity Consults: Volume 2, Number 4
Obesity and the Cardiovascular System

This activity is supported by an educational grant from Eisai, Inc. and Vivus, Inc.

Obesity is associated with a wide range of comorbid conditions, including diabetes, hypertension, sleep apnea, and…
More »
Meeting News Coverage Video
4138851692001 th

VIDEO: EMBRACE-STEMI yields 'hypothesis-generating' results despite drug not meeting study endpoints

March 27, 2015
SAN DIEGO — In this video, C. Michael Gibson, MD, of Beth Israel Deaconess Medical Center, Harvard Medical…
More »
CME
Obesity Consults: Volume 2, Number 2 Obesity Forum 2014 Highlights

Obesity Consults: Volume 2, Number 2
Obesity Forum 2014 Highlights

This activity is supported by educational grants from Takeda Pharmaceuticals International, Inc., US Region and Orexigen Therapeutics, Inc; Eisai, Inc.; Novo Nordisk; Vivus, Inc.

Management of obesity is complex, factoring in psychological, environmental, and physiologic causes. Treatment options…
More »
morganatic-roan